Testimony: FDA Commissioner says FDA has limited authority over compounding pharmacies to prevent meningitis outbreak
During a four-hour hearing Nov. 14 led by the chairman of the House Energy and Commerce oversight subcommittee, FDA Commissioner Margaret Hamburg was asked if the FDA could have prevented the recent fungal meningitis outbreak.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
